A hard lesson learnt: Commonwealth v Sanofi

In June this year, the first Full Federal Court decision on this issue was handed down following a ten-year damages battle between the Commonwealth and Sanofi relating to Apotex’s ‘delayed’ launch of generic clopidogrel following PI.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Sanofi v Amgen antibody case lands front of queue at UPC

6 June 2023 Big pharma company picks pan-European venue for next leg of global dispute | IT issues potentially behind new court's low revocation count | Nearly half a million opt-outs registered.

Big Pharma

Sanofi backed by big pharma and more in SCOTUS clash

More on this story

Big Pharma

Sanofi v Amgen antibody case lands front of queue at UPC

6 June 2023 Big pharma company picks pan-European venue for next leg of global dispute | IT issues potentially behind new court's low revocation count | Nearly half a million opt-outs registered.

Big Pharma

Sanofi backed by big pharma and more in SCOTUS clash

More on this story

Big Pharma

Sanofi v Amgen antibody case lands front of queue at UPC

6 June 2023 Big pharma company picks pan-European venue for next leg of global dispute | IT issues potentially behind new court's low revocation count | Nearly half a million opt-outs registered.

Big Pharma

Sanofi backed by big pharma and more in SCOTUS clash